JPWO2022009698A1 - - Google Patents
Info
- Publication number
- JPWO2022009698A1 JPWO2022009698A1 JP2022535021A JP2022535021A JPWO2022009698A1 JP WO2022009698 A1 JPWO2022009698 A1 JP WO2022009698A1 JP 2022535021 A JP2022535021 A JP 2022535021A JP 2022535021 A JP2022535021 A JP 2022535021A JP WO2022009698 A1 JPWO2022009698 A1 JP WO2022009698A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020116583 | 2020-07-06 | ||
| JP2020116583 | 2020-07-06 | ||
| PCT/JP2021/024125 WO2022009698A1 (ja) | 2020-07-06 | 2021-06-25 | ペプチドおよびそれを含む複合体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2022009698A1 true JPWO2022009698A1 (https=) | 2022-01-13 |
| JPWO2022009698A5 JPWO2022009698A5 (https=) | 2024-07-02 |
| JP7740715B2 JP7740715B2 (ja) | 2025-09-17 |
Family
ID=79553070
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022535021A Active JP7740715B2 (ja) | 2020-07-06 | 2021-06-25 | ペプチドおよびそれを含む複合体 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP7740715B2 (https=) |
| WO (1) | WO2022009698A1 (https=) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009539357A (ja) * | 2006-06-06 | 2009-11-19 | ヘルムホルツ−ツェントルム フュア インフェクツィオンスフォルシュンク ゲーエムベーハー | リウマチ熱関連ペプチド（ｐａｒｆ）および診断マーカーとしてのその使用 |
| WO2014119753A1 (ja) * | 2013-01-31 | 2014-08-07 | 学校法人 東京薬科大学 | マイオスタチン阻害ペプチド |
| JP2016523274A (ja) * | 2013-06-26 | 2016-08-08 | ザイジェン インフラメーション リミテッド | 種々の疾患を処置するためのｊｎｋシグナル伝達経路の新規の細胞透過性ペプチド阻害剤の使用 |
| JP2017528417A (ja) * | 2014-06-12 | 2017-09-28 | ザ ユニヴァーシティ オブ バース | 薬物送達強化剤 |
| WO2018030432A1 (ja) * | 2016-08-10 | 2018-02-15 | 学校法人東京薬科大学 | ペプチドもしくはその薬学的に許容される塩、またはそれらのプロドラッグ |
| JP2020059663A (ja) * | 2018-10-09 | 2020-04-16 | 学校法人東京薬科大学 | ペプチドもしくはその薬学的に許容される塩、またはそれらのプロドラッグ |
-
2021
- 2021-06-25 WO PCT/JP2021/024125 patent/WO2022009698A1/ja not_active Ceased
- 2021-06-25 JP JP2022535021A patent/JP7740715B2/ja active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009539357A (ja) * | 2006-06-06 | 2009-11-19 | ヘルムホルツ−ツェントルム フュア インフェクツィオンスフォルシュンク ゲーエムベーハー | リウマチ熱関連ペプチド（ｐａｒｆ）および診断マーカーとしてのその使用 |
| WO2014119753A1 (ja) * | 2013-01-31 | 2014-08-07 | 学校法人 東京薬科大学 | マイオスタチン阻害ペプチド |
| JP2016523274A (ja) * | 2013-06-26 | 2016-08-08 | ザイジェン インフラメーション リミテッド | 種々の疾患を処置するためのｊｎｋシグナル伝達経路の新規の細胞透過性ペプチド阻害剤の使用 |
| JP2017528417A (ja) * | 2014-06-12 | 2017-09-28 | ザ ユニヴァーシティ オブ バース | 薬物送達強化剤 |
| WO2018030432A1 (ja) * | 2016-08-10 | 2018-02-15 | 学校法人東京薬科大学 | ペプチドもしくはその薬学的に許容される塩、またはそれらのプロドラッグ |
| JP2020059663A (ja) * | 2018-10-09 | 2020-04-16 | 学校法人東京薬科大学 | ペプチドもしくはその薬学的に許容される塩、またはそれらのプロドラッグ |
Non-Patent Citations (2)
| Title |
|---|
| OKAMOTO, HIDEYUKI ET AL.: "Inactivation of myostatin by photo-oxygenation using catalyst-functionalized peptides", CHEM. COMMUN., vol. 55, JPN7021002903, 2019, pages 9108 - 9111, ISSN: 0005591941 * |
| TAKAYAMA, KENTARO ET AL.: "Chain-Shortened Myostatin Inhibitory Peptides Improve Grip Strength in Mice", ACS MED. CHEM. LETT., vol. 10, JPN6021029705, 2019, pages 985 - 990, ISSN: 0005591942 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP7740715B2 (ja) | 2025-09-17 |
| WO2022009698A1 (ja) | 2022-01-13 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A529 | Written submission of copy of amendment under article 34 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A5211 Effective date: 20221213 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230111 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240624 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240624 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250513 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250709 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20250805 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20250828 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7740715 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |